EVOLUTION OF PRESENCE OF PREDOMINANT NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA

被引：0
|
作者：
Refai, T. [1 ]
Millier, A. [2 ]
Toumi, M. [3 ]
机构：
[1] Creativ Ceut, Tunis, Tunisia
[2] Creativ Ceut, Paris, France
[3] Univ Marseille, Marseille, France
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.290
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH7
引用
收藏
页码：A766 / A766
页数：1
相关论文
共 50 条
  • [21] Folic Acid and Vitamin B12 Supplementation on Male Patients with Schizophrenia Predominant Negative Symptoms
    Simamora, Rona Hanani
    Loebis, Bahagia
    Husada, Muhammad Surya
    Effendy, Elmeida
    [J]. CURRENT NUTRITION & FOOD SCIENCE, 2020, 16 (01) : 98 - 104
  • [22] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Marc Krause
    Yikang Zhu
    Maximilian Huhn
    Johannes Schneider-Thoma
    Irene Bighelli
    Adriani Nikolakopoulou
    Stefan Leucht
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 : 625 - 639
  • [23] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Krause, Marc
    Zhu, Yikang
    Huhn, Maximilian
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Nikolakopoulou, Adriani
    Leucht, Stefan
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (07) : 625 - 639
  • [24] Psychiatric Inpatient Healthcare Resource Utilization and Treatment Patterns Among Patients With Predominant Negative Symptoms in Schizophrenia
    Patel, Rashmi
    Mehta, Darshan
    Kadakia, Aditi
    Won, Yida
    Dembek, Carole
    Williams, Gwilym
    Huang, Xueyan
    Zeni, Courtney
    Pikalov, Andrei
    [J]. CNS SPECTRUMS, 2023, 28 (02) : 222 - 223
  • [25] Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial
    Debelle, M.
    Nemeth, G.
    Szalai, E.
    Szatmari, B.
    Harsanyi, J.
    Barabassy, A.
    Laszlovszky, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S510 - S510
  • [26] Clinical improvement of patients with predominant negative symptoms of schizophrenia: Post-hoc analysis of cariprazine versus risperidone
    Sebe, B.
    Barabassy, A.
    Laszlovszky, I.
    Szatmari, B.
    Harsanyi, J.
    Acsai, K.
    Earley, W.
    Patel, M.
    Nemeth, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S275 - S275
  • [27] Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone
    Nemeth, Bertalan
    Molnar, Anett
    Akehurst, Ron
    Horvath, Margit
    Koczian, Kristof
    Nemeth, Gyorgy
    Gotze, Arpad
    Voko, Zoltan
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (08) : 639 - 648
  • [28] Amisulpride: Is there a treatment for negative symptoms in schizophrenia patients?
    Storosum, JG
    Elferink, AJA
    van Zwieten, BJ
    van Strik, R
    Hoogendijk, WJG
    Broekmans, AW
    [J]. SCHIZOPHRENIA BULLETIN, 2002, 28 (02) : 193 - 201
  • [29] Association of hypotestosteronemia with negative symptoms in patients with Schizophrenia
    Singh, Mamta
    Solanki, R. K.
    Swami, M. K.
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2015, 57 (05) : S100 - S101
  • [30] Morphophenotypical patterns in patients with negative symptoms in schizophrenia
    Kornetova, E.
    Semke, A. V.
    Kornetov, A. N.
    Dmitrieva, E. G.
    Dubrovskaya, V. V.
    Bokhan, N. A.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S818 - S818
12345